Entecavir: stability and drug-excipient compatibility

Abstract Entecavir is an inhibitor of hepatitis B virus (HBV) DNA synthesis that has been widely prescribed in the treatment of chronic infections caused by the virus. Production of generic ETV drugs is an ongoing global endeavor, with particular significance for developing countries that rely on im...

Full description

Saved in:
Bibliographic Details
Main Authors: Ariadne Botto Fiorot, Clayton Raynan dos Santos, Thiago Padovani Xavier, Taisa Shimosakai de Lira, Marcelo Antonio de Oliveira
Format: Article
Language:English
Published: Universidade de São Paulo 2025-01-01
Series:Brazilian Journal of Pharmaceutical Sciences
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502025000100304&lng=en&tlng=en
Tags: Add Tag
No Tags, Be the first to tag this record!